Clinical trial
Dose Escalation Study of the Aeris Bronchoscopic Lung Volume Reduction (BLVR) System in Patients With Advanced Emphysema
NCT00205920 is registered in ClinicalTrials.gov with Aeris Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dose Escalation Study of the Aeris Bronchoscopic Lung Volume Reduction (BLVR) System in Patients With Advanced Emphysema
- Lead sponsor
- Aeris Therapeutics
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- May 31, 2005
- Completion date
- May 31, 2007
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.